Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ocular Therapeutix (OCUL)
NASDAQ:OCUL
Holding OCUL?
Track your performance easily
Ocular Therapeutix (OCUL) Ownership Overview
15.49% Insiders
9.62% Mutual Funds
56.72% Other Institutional Investors
11.13% ETFs
7.04% Public Companies and
Individual Investors
The ownership structure of Ocular Therapeutix (OCUL) stock is a mix of institutional, retail, and individual investors. Approximately 77.48% of the company’s stock is owned by Institutional Investors, 15.49% is owned by Insiders, and 7.04% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Aug 27, 2024 | Sanjay Nayak Cso | xxxxxxxxxxxxx | $16525 |
| Aug 27, 2024 | Pravin Dugel Executive Chairman, President And Ceo,director | xxxxxxxxxxxxx | $188338 |
| May 28, 2024 | Sanjay Nayak Cso | xxxxxxxxxxxxx | $13280 |
| May 28, 2024 | Pravin Dugel Executive Chairman, President And Ceo,director | xxxxxxxxxxxxx | $125215 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $8700000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,420,176 | Insider | 7.90% | 109,049,145 | |
| 8,591,401 | Insider | 5.46% | 75,432,501 | |
| 7,822,312 | Institution | 4.98% | 68,679,899 | |
| 6,897,968 | Institution | 4.39% | 60,564,159 | |
| 6,390,742 | Institution | 4.06% | 56,110,715 | |
| 3,324,468 | Institution | 2.11% | 29,188,829 | |
| 1,719,204 | Institution | 1.09% | 15,094,611 | |
| 1,592,836 | Institution | 1.01% | 13,985,100 | |
| 1,309,457 | Institution | 0.83% | 11,497,032 | |
| 1,069,183 | Institution | 0.68% | 9,387,427 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,897,968 | Institution | 4.39% | 60,564,159 | |
| 1,719,204 | Institution | 1.09% | 15,094,611 | |
| 1,592,836 | Institution | 1.01% | 13,985,100 | |
| 1,309,457 | Institution | 0.83% | 11,497,032 | |
| 790,988 | Institution | 0.50% | 6,944,875 | |
| 450,380 | Institution | 0.29% | 3,954,336 | |
| 427,500 | Institution | 0.27% | 3,753,450 | |
| 410,100 | Institution | 0.26% | 3,600,678 | |
| 336,267 | Institution | 0.21% | 2,952,424 | |
| 300,000 | Institution | 0.19% | 2,634,000 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,643,156 | Institution | 2.95% | 48,892,433 | |
| 4,246,335 | Institution | 2.70% | 37,282,821 | |
| 1,899,480 | Institution | 1.21% | 20,001,524 | |
| 1,394,094 | Institution | 0.89% | 12,240,145 | |
| 709,299 | Institution | 0.45% | 7,468,918 | |
| 614,198 | Institution | 0.39% | 5,478,646 | |
| 458,701 | Institution | 0.29% | 4,027,395 | |
| 334,399 | Institution | 0.21% | 3,521,221 | |
| 356,324 | Institution | 0.23% | 3,128,525 | |
| 319,600 | Institution | 0.20% | 2,850,832 |
FAQ
Who Owns Ocular Therapeutix (OCUL)?
According to the latest TipRanks data, approximately 56.72% of the company's stock is held by institutional investors, 15.49% is held by insiders, and 7.04% is held by retail investors.
What percentage of Ocular Therapeutix (OCUL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 56.72% of Ocular Therapeutix (OCUL) stock is held by institutional investors.
What percentage of Ocular Therapeutix (OCUL) stock is held by retail investors?
According to the latest TipRanks data, approximately 7.04% of Ocular Therapeutix (OCUL) stock is held by retail investors.
Who owns the most shares of Ocular Therapeutix (OCUL)?
Behzad Aghazadeh owns the most shares of Ocular Therapeutix (OCUL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.